Lupin Ltd. Technical Momentum Shifts Amid Bearish Signals

8 hours ago
share
Share Via
Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a more pronounced bearish stance. Recent technical indicators including MACD, RSI, Bollinger Bands, and moving averages signal a cautious outlook for investors, despite the company’s resilient long-term returns compared to the broader Sensex.
Lupin Ltd. Technical Momentum Shifts Amid Bearish Signals

Technical Trend Overview

The technical landscape for Lupin Ltd. has deteriorated over recent weeks. The weekly MACD indicator, a key momentum oscillator, currently registers a bearish signal, while the monthly MACD remains mildly bearish. This suggests that the short-term momentum is weakening more rapidly than the longer-term trend, which still shows some resilience but is under pressure.

Similarly, the Relative Strength Index (RSI) on both weekly and monthly charts shows no definitive signal, indicating a lack of clear momentum either way. However, the absence of a bullish RSI signal amid other bearish indicators points to a subdued price action environment.

Bollinger Bands, which measure volatility and potential price breakouts, are signalling bearish trends on both weekly and monthly timeframes. The price currently trades near the lower band, implying increased downside pressure and heightened volatility risk.

Moving Averages and Momentum Oscillators

Daily moving averages for Lupin Ltd. have turned bearish, with the current price of ₹2,100.00 falling below key short-term and medium-term averages. This technical configuration often signals a continuation of downward momentum unless a strong reversal catalyst emerges.

The Know Sure Thing (KST) indicator, which aggregates multiple rate-of-change calculations, confirms this bearish momentum on the weekly chart and remains mildly bearish on the monthly scale. This dual timeframe weakness reinforces the notion that the stock is under selling pressure across both short and intermediate horizons.

Volume and Dow Theory Signals

On-Balance Volume (OBV) analysis shows no clear trend on the weekly chart but mildly bearish signals on the monthly chart. This suggests that volume flows are not strongly supporting any upward price movement, a concern for bulls looking for confirmation of strength.

Dow Theory assessments align with this cautious stance, showing no clear trend on the weekly timeframe and a mildly bearish outlook monthly. This lack of confirmation from a classical trend analysis framework adds to the technical uncertainty.

Price Action and Volatility

On 24 Sep 2026, Lupin’s stock closed at ₹2,100.00, down 0.95% from the previous close of ₹2,120.10. The intraday range was between ₹2,090.35 and ₹2,127.00, reflecting moderate volatility within a narrowing band. The 52-week high stands at ₹2,530.00, while the 52-week low is ₹1,900.30, placing the current price closer to the lower end of its annual range.

Comparative Returns Versus Sensex

Despite recent technical weakness, Lupin Ltd. has outperformed the Sensex over multiple time horizons. The stock delivered a 2.58% return over the past week compared to Sensex’s 0.66%, and a 4.70% gain over the last year against the Sensex’s decline of 8.86%. Over three and five years, Lupin’s returns have been particularly impressive at 91.42% and 123.31% respectively, dwarfing the Sensex’s 13.36% and 24.95% gains. However, the 10-year return of 41.06% trails the Sensex’s 161.01%, reflecting sector-specific challenges over the longer term.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

Mojo Score and Rating Revision

Lupin’s current Mojo Score stands at 53.0, reflecting a Hold rating, downgraded from a Buy on 14 Aug 2026. This adjustment aligns with the deteriorating technical indicators and the cautious outlook from multiple momentum and trend-following tools. The mid-cap pharmaceutical company now faces a more challenging technical environment, warranting a more conservative stance from investors.

Sector and Industry Context

Operating within the Pharmaceuticals & Biotechnology sector, Lupin faces sector-specific headwinds including regulatory scrutiny, pricing pressures, and competitive dynamics. The technical weakness observed may partly reflect broader sector volatility, as well as company-specific factors. Investors should weigh these technical signals alongside fundamental developments and sector trends.

Implications for Investors

The convergence of bearish signals across MACD, Bollinger Bands, moving averages, and KST suggests that Lupin Ltd. is currently in a phase of technical weakness. While the absence of strong RSI signals indicates no immediate oversold condition, the overall momentum points to potential further downside or consolidation near current levels.

Investors with a medium to long-term horizon may consider the stock’s strong multi-year returns and sector positioning, but should remain vigilant for confirmation of trend reversals before increasing exposure. Short-term traders might find the current technical setup less favourable, given the predominance of bearish indicators.

Considering Lupin Ltd.? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this mid-cap with top-rated alternatives now!

  • - Better options discovered
  • - Pharmaceuticals & Biotechnology + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Conclusion

Lupin Ltd.’s recent technical parameter changes highlight a shift towards a more bearish momentum, underscored by weakening MACD, bearish Bollinger Bands, and declining moving averages. While the stock’s long-term performance remains robust relative to the Sensex, the current technical signals counsel caution. Investors should monitor for any signs of technical recovery or further deterioration before adjusting their positions.

Given the mid-cap status and sector challenges, Lupin’s Hold rating reflects a balanced view, recognising both the company’s historical strength and the present technical headwinds. As always, a comprehensive approach combining technical and fundamental analysis will best serve investors navigating this evolving landscape.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Lupin Ltd. is Rated Hold by MarketsMOJO
Sep 19 2026 10:10 AM IST
share
Share Via
Lupin Ltd. is Rated Hold by MarketsMOJO
Sep 08 2026 10:10 AM IST
share
Share Via
Lupin Ltd. is Rated Hold by MarketsMOJO
Aug 28 2026 10:10 AM IST
share
Share Via